-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$22.5038.89% Upside
Evolus, Inc. Frequently Asked Questions
-
What analysts cover Evolus, Inc.?
Evolus, Inc. has been rated by research analysts at Barclays, Mizuho Securities in the past 90 days.